Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Elite Pharma Acquires Trimipramine ANDA from Mikah Pharma 11
Elite Pharma Acquires Thirteen Abbreviated New Drug Application from Mikah Pharma 12
Partnerships 13
Elite Pharma Amends Co-Development and Licensing Agreement with SunGen Pharma 13
Elite Pharma Enters into Co-Development and Licensing Agreement with SunGen Pharma 14
Licensing Agreements 15
Elite Pharma Enters into Licensing Agreement with Glenmark Pharma 15
Glenmark Pharma Enters into Licensing Agreement with Elite Pharma 16
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18
Equity Offering 19
Elite Pharma to Raise USD40 Million in Private Placement of Shares 19
Elite Pharma to Raise Funds through Private Placement of Shares 20
Elite Pharma Announces Private Placement of Shares for USD40 Million 21
Elite Pharma Announces Private Placement Of Preferred Stock For US$5 Million 22
Elite Pharmaceuticals Inc – Key Competitors 23
Elite Pharmaceuticals Inc – Key Employees 24
Elite Pharmaceuticals Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 09, 2018: Elite Pharmaceuticals reports financial results for the first quarter of fiscal year 2019 ended June 30, 2018 26
Jun 14, 2018: Elite Pharmaceuticals Announces Financial Results for the Fiscal Year Ended March 31, 2018 27
Feb 09, 2018: Elite Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017 28
Nov 09, 2017: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017 29
Aug 09, 2017: Elite Pharmaceuticals Reports Financial Results For The First Quarter Of Fiscal Year 2018 Ended June 30, 2017 30
Jun 14, 2017: Elite Pharmaceuticals, Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information 31
Feb 09, 2017: Elite Pharmaceuticals Reports Results For Third Quarter Of Fiscal Year 2017 32
Corporate Communications 33
Aug 07, 2018: Elite Pharmaceuticals appoints Aqeel A. Fatmi to its Board of Directors 33
Product News 34
Oct 24, 2018: Elite Pharmaceuticals reports positive results from a pivotal bioequivalence study 34
08/30/2017: Elite Pharmaceuticals to Present ELI-200 (SequestOx) Data at PAINWeek 2017 National Conference 35
07/07/2017: Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx 36
05/25/2017: Elite Pharmaceuticals SequestOx Study Results Expected In July 37
03/13/2017: Elite Pharmaceuticals Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx 38
02/08/2018: Elite Pharmaceuticals and SunGen Pharma File ANDA 39
01/30/2018: Elite Pharmaceuticals Reports Positive Topline Results from SequestOx Pilot Study 40
Jan 17, 2017: Elite Pharmaceuticals Reports Positive Topline Results From A Pivotal Bioequivalence Study For A Generic OxyContin 41
Jan 10, 2018: Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic 42
Product Approvals 43
Jan 23, 2017: Elite Reports On SequestOx FDA End-of-Review Meeting 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Elite Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Elite Pharma Acquires Trimipramine ANDA from Mikah Pharma 11
Elite Pharma Acquires Thirteen Abbreviated New Drug Application from Mikah Pharma 12
Elite Pharma Amends Co-Development and Licensing Agreement with SunGen Pharma 13
Elite Pharma Enters into Co-Development and Licensing Agreement with SunGen Pharma 14
Elite Pharma Enters into Licensing Agreement with Glenmark Pharma 15
Glenmark Pharma Enters into Licensing Agreement with Elite Pharma 16
Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17
Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18
Elite Pharma to Raise USD40 Million in Private Placement of Shares 19
Elite Pharma to Raise Funds through Private Placement of Shares 20
Elite Pharma Announces Private Placement of Shares for USD40 Million 21
Elite Pharma Announces Private Placement Of Preferred Stock For US$5 Million 22
Elite Pharmaceuticals Inc, Key Competitors 23
Elite Pharmaceuticals Inc, Key Employees 24
Elite Pharmaceuticals Inc, Subsidiaries 25
List of Figures
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9